![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/novo-nordisk-and-eli-lilly-likely-to-maintain-clout-in-glp-1r-market-globaldata/112679227?utm_source=top_news&utm_medium=sectionListing
https://www.fiercepharma.com/pharma/new-study-suggesting-potential-suicidal-ideation-risk-tied-novos-ozempic-adds-ongoing-safety
https://www.fiercepharma.com/pharma/novo-create-50-jobs-new-220m-raw-ingredients-plant-will-support-ozempic-and-wegovy
https://www.reuters.com/business/healthcare-pharmaceuticals/doctors-struggle-get-wegovy-older-americans-with-heart-disease-2024-08-15/
https://www.fiercepharma.com/pharma/after-icodec-rejection-novo-nordisk-plots-2024-fda-filing-once-weekly-insulin-and
https://www.globenewswire.com/news-release/2024/08/12/2928416/0/en/Novo-Nordisk-A-S-Share-repurchase-programme.html
https://www.globenewswire.com/news-release/2024/08/12/2928366/0/en/Novo-Nordisk-A-S-Trading-in-Novo-Nordisk-shares-by-board-members-executives-and-associated-persons.html
https://www.indianpharmapost.com/news/novo-nordisks-h1-sales-increased-by-24-in-danish-kroner-16018
https://www.fiercepharma.com/marketing/novo-nordisk-found-breach-uk-marketing-rules-2022-ceo-interview-wegovy
https://www.biospace.com/drug-development/5-obesity-readouts-to-watch-in-the-second-half-of-2024